144 results match your criteria: "The Operation Eyesight Universal Institute for Eye Cancer.[Affiliation]"
Int Ophthalmol
January 2020
Ophthalmic Biophysics (AM), L V Prasad Eye Institute, Hyderabad, India.
Purpose: To compare the clinical presentation and outcomes of retinoblastoma (RB) based on age at presentation.
Methods: Retrospective comparative study of 1940 eyes of 1450 children with RB.
Results: Presentation of RB with enlarged eyeball and eyelid swelling (2% and < 1% in ≤ 1 year, 4% and 2% in > 1-2 years, 7% and 2% in > 2-3 years, and 12% and 4% in > 3 years; p < 0.
Semin Ophthalmol
January 2020
Mark Nathaniel Thadikonda and Vijayamma Nannepaga Centre for Eye Care Education and Ophthalmic Biophysics (AM), L V Prasad Eye Institute, Hyderabad, India.
Purpose: To study the factors influencing the response to treatment with interferon alfa 2b (IFN) in ocular surface squamous neoplasia (OSSN)Methods: Retrospective study of 91 patientsResults: The mean age at presentation of patients with OSSN was 58 years (median, 60 years; range, 21 to 83 years). The mean number of clock hours of conjunctiva/cornea/limbus involvement by the tumor was 6 (median, 6; range, 1 to 12). The mean duration of topical IFN was 3 months (median, 3 months; range, 1 to 6 months) and the mean number of subconjunctival injections of IFN was 2 (median, 2; range, 0 to 6), till complete tumor regression or initiation of alternate treatment.
View Article and Find Full Text PDFIndian J Ophthalmol
July 2019
Kanupriya Dalmia Ophthalmic Pathology Laboratory, L.V. Prasad Eye Institute, Mithu Tulsi Chanrai Campus, Bhubaneswar, Odisha, India.
Myofibroma is a rare benign mesenchymal tumor of uncertain histogenesis. A six-year-old boy presented with a unilateral lower eyelid mass of six weeks' duration. MRI revealed a circumscribed mass in the inferolateral orbit with bony erosion.
View Article and Find Full Text PDFIndian J Ophthalmol
July 2019
Cornea and Refractive Surgery Services, L V Prasad Eye Institute, Vijayawada, Andhra Pradesh, India.
Ophthalmol Retina
October 2019
Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L. V. Prasad Eye Institute, Hyderabad, India. Electronic address:
Purpose: To evaluate the vascular structure within combined hamartoma of retina and retinal pigment epithelium (CHRRPE) lesions using OCT angiography (OCTA).
Design: Multicenter, retrospective, observational analysis, PARTICIPANTS: Twenty eyes of patients diagnosed with CHRRPE.
Methods: Retrospective analysis of color fundus photographs, OCT, and OCTA of 20 eyes with CHRRPE.
Oman J Ophthalmol
January 2019
The Operation Eyesight Universal Institute for Eye Cancer, Hyderabad, Telangana, India.
Schwannoma is a rare benign tumor, which is more commonly found elsewhere in the body along myelin-producing peripheral nerves and is rarely reported within the eye. In this report, we describe two adult patients presenting with a choroidal mass lesion and neovascular glaucoma who underwent enucleation with clinical differential diagnoses of choroidal melanoma and choroidal hemangioma. Histopathology confirmed the diagnosis of choroidal schwannoma.
View Article and Find Full Text PDFOphthalmic Plast Reconstr Surg
January 2020
Kanupriya Dalmia Ophthalmic Pathology Laboratory, LV Prasad Eye Institute, MTC Campus, Bhubaneswar, India.
Trichofolliculoma is a rare benign tumor of the skin, with distinct pilar differentiation and a predilection for the head and neck. To the best of the authors' knowledge, only 10 cases of eyelid trichofolliculoma has been described in the English literature. Moreover, these benign hair follicle lesions have been reported to clinically mimic eyelid malignancy.
View Article and Find Full Text PDFOphthalmic Plast Reconstr Surg
December 2019
Ophthalmic Pathology Service, Wills Eye Hospital, Philadelphia, Pennsylvania, U.S.A.
Purpose: To compare clinical, optical coherence tomography (OCT), and fundus autofluorescence (FAF) characteristics of peripapillary vs macular variants of combined hamartoma of the retina and retinal pigment epithelium (combined hamartoma).
Design: Retrospective observational, comparative case series.
Methods: Setting: Multicenter collaborative study.
Int Ophthalmol
October 2019
Ophthalmic Pathology Laboratory (DKM), L V Prasad Eye Institute, Hyderabad, India.
Purpose: To study the concordance between intra-operative rapid frozen section and permanent section diagnoses of surgical margins following wide surgical excisional biopsy of malignant eyelid tumors.
Methods: This is a retrospective study of 120 cases and 429 frozen section slides.
Results: Of 120 cases, 75 (63%) had sebaceous gland carcinoma, 34 (28%) had basal cell carcinoma, and 11 (9%) had squamous cell carcinoma.
Oman J Ophthalmol
January 2018
Ophthalmic Pathology Service, Apollo Health City, Hyderabad, Telangana, India.
Isolated eyelid Rosai-Dorfman disease without orbital disease or systemic involvement is very rare and needs a high degree of suspicion. In this report, we describe a 16-year-old boy who presented with isolated eyelid Rosai-Dorfman disease involving the right upper eyelid. The lesion was treated by surgical debulking followed by intralesional steroid injection for the residual lesion.
View Article and Find Full Text PDFAm J Ophthalmol
February 2019
Ophthalmic Pathology Laboratory, L. V. Prasad Eye Institute, Hyderabad, India.
Purpose: We studied the incidence, treatment, and outcome of ocular and periocular tumors in patients with xeroderma pigmentosum (XP).
Design: Retrospective case series.
Methods: This single-institution study included 120 patients with XP who underwent intervention with excisional biopsy, enucleation, or orbital exenteration.
Oman J Ophthalmol
January 2018
Ocular Oncology Service, The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, Telangana, India.
Background: Langerhans cell histiocytosis (LCH) of the orbit is a rare clinical entity with a diagnostic and therapeutic dilemma.
Materials And Methods: This was a retrospective study of eight patients with orbital LCH.
Results: All eight patients in our series were male, and the mean age at presentation was 8 years (median 6 years; range, 7 months-23 years).
Community Eye Health
January 2018
Head of The Operation Eyesight Universal Institute for Eye Cancer: LV Prasad Eye Institute, Hyderabad, India.
Community Eye Health
January 2018
Consultant Radiation Oncologist: L V Prasad Eye Institute & Senior Consultant, Professor and Head: Department of Radiation Oncology, Director: Apollo Cancer Hospital, Hyderabad, India.
Retina
September 2019
Ocular Oncology Service, The Operation Eyesight Universal Institute for Eye Cancer, L. V. Prasad Eye Institute, Hyderabad, India.
Purpose: To study the clinical presentation and treatment outcome of patients who underwent inadvertent intraocular surgery before the diagnosis of retinoblastoma.
Design: Retrospective study of 14 patients who had undergone an inadvertent intraocular surgery before the diagnosis of retinoblastoma.
Results: The mean age at presentation to the ocular oncology clinic was 69 months.
Curr Top Med Chem
July 2018
The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Bhubaneswar, India.
Cancer cells alter their metabolism to support the uninterrupted supply of biosynthetic molecules required for continuous proliferation. Glucose metabolism is frequently reprogrammed in several tumors in addition to fatty acid, amino acid and glutamine metabolism. Pyruvate Dehydrogenase Kinase (PDK) is a gatekeeper enzyme involved in altered glucose metabolism in tumors.
View Article and Find Full Text PDFInt Ophthalmol
June 2019
The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, 500034, India.
Purpose: To evaluate outcomes of ocular surface squamous neoplasia (OSSN) based on American Joint Committee on Cancer (AJCC), 8th edition classification.
Methods: Retrospective, non-randomized interventional case series of 127 patients (136 eyes) with OSSN.
Results: On the basis of the AJCC (eighth edition), OSSN was classified as per T category as Tis (n = 14, 10%), T1 (n = 0), T2 (n = 4, 3%), T3 (n = 113, 83%), and T4 (n = 5, 4%).
Ophthalmic Plast Reconstr Surg
May 2019
Ophthalmic Pathology Service, Apollo Health City, Hyderabad, India.
Retina
July 2019
The Ocular Oncology Service, The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, India.
Purpose: To discuss the importance of routine ophthalmic examination of parents and siblings of retinoblastoma (RB) patients.
Methods: Prospective nonrandomized observational/interventional case series of consecutive families of 131 RB patients.
Results: Routine ophthalmic examination of families (parents and siblings) of 131 consecutive newly diagnosed RB patients, including 262 parents and 23 siblings, revealed spontaneously regressed RB in at least 1 parent of 10 (8%) patients and active RB in at least 1 sibling of 3 (2%) patients.
Eye (Lond)
March 2018
The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.
PurposeThe purpose of this study is to discuss the clinical presentation, management, and outcomes of patients with primary orbital Ewing sarcoma family of tumors (ESFTs).Patients and methodsRetrospective study of 12 patients with biopsy-proven primary orbital ESFT.ResultsThe mean age at presentation of primary orbital ESFT was 12 years (median, 8 years; range, 5 months to 28 years).
View Article and Find Full Text PDFRetina
February 2019
Ocular Oncology Service, The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, India.
Purpose: To study the clinical presentation, treatment, and outcome of patients with retinoblastoma (RB) in India.
Methods: Retrospective study of 1,457 patients with RB (2,074 eyes).
Results: The mean age at presentation of RB was 29 months (median, 24 months; range, <1-370 months).
Oman J Ophthalmol
January 2017
The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, Telangana, India.
Orbit
February 2018
c Oculoplasty and Ocular Oncology Services , EyeHub Hospital, Faridabad , Haryana , India.